Roche’s Genentech unit has looked internally for its new chief executive, appointing Ashley Magargee to the role following the departure of Alexander Hardy last month. Magargee has been serving ...

in the hope of preparing a regulatory filing for the EAPP test in 2025. Roche’s Genentech division reported disappointing top-line results from its highly-anticipated phase 3 trial of anti ...

February 12, 2025--Genentech, a member of the Roche Group (SIX ... The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022 ...

Blood Test Could Make Cancer Treatments Safer ... Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep. 17, 2024 — According to new research, 80% of patients ...

At close: February 17 at 5:31:07 PM GMT+1 ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...

Body & Mind Incredible progress is being made in health and medicine – every day we seem to broaden our understanding of how to maximize physical and mental health, treat and cure illness and ...